Delivery Order SPE2DB22D2211-SPE2DB25FSECP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,378.26 to AmerisourceBergen Drug Corp for WIXELA 500-50 inhalers (60-count) on September 2, 2025, with ultimate completion by September 3, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a small-value transaction typical of routine pharmaceutical supply replenishment orders. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work from its...
- The Defense Logistics Agency awarded a delivery order valued at $2,374.92 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhalers (60-count), with an ultimate completion date of August 29, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a direct fulfillment of pharmaceutical supply needs through AmerisourceBergen's existing contract vehicle. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,948.02 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and was fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $2,141.04 delivery order to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price contract, which is a child order under a larger contract vehicle, involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. WIXELA is a combination inhalation medication used in respiratory therapy, reflecting...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for WIXELA 250-50 inhalation powder (60-unit package) with a ceiling value of $1,733.01. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,548.77 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the pharmaceutical product Wixela 250-50 inhaler with 60 doses. The contract represents a non-competitive, non-set-aside delivery order with an ultimate completion date of September 3, 2025, and is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,022.88 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhalation powder (60 doses), a combination pharmaceutical product, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed on August 27, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,290.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for WIXELA 250-50 INHUB 60S, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania by August 12, 2025. This is a non-set-aside, competitively awarded contract issued as a child delivery order under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,231.35 for WIXELA 250-50 INHUB 60S, a pharmaceutical product, with a completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child task order under AmerisourceBergen Drug Corp's larger contract vehicle with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,483.86 to AmerisourceBergen Drug Corp for WIXELA 100-50 inhalation powder, a combination asthma and COPD medication. Issued on August 5, 2025, with an ultimate completion date of August 6, 2025, this firm fixed-price delivery order was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSECPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,496.16 to AmerisourceBergen Drug Corp on September 3, 2025, for WIXELA 250-50 inhaler units (60-count). This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor for military and veteran healthcare systems. The parent IDC supports the supply of a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide. This delivery order represents one of numerous competitive awards the company has received for pharmaceutical products under the DLA's medical supply chain framework, demonstrating the contractor's established capability to meet federal procurement requirements for essential medications and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/3/25 |